Optional text-derived evidence extracted beside the imported chart. Each signal stays traceable to source text.
No extracted signals for this patient
Reprocess an import with text enrichment to attach suggested evidence to this patient record.
Loading...
Most recent values are summarized here so the timeline can stay readable.
Loading...
Loading...
Recent chart, workflow, AI, cohort, and audit events shown in the user's local time.
28, more source rows below
Loading...
Recent Notes
Latest narrative evidence, clipped for scanning.
Loading...
Reports
Recent report headers and excerpts.
Loading...
Full Imported Source Data
Audit view for imported records. Kept collapsed so the working chart remains usable.
Loading...
PHM saved action
PHM action: SURVIVORSHIP_PLAN_DUE
status=in_review | imported | outreach=portal 2026-03-12 11:10 | next review=2026-07-17 | Review evidence for Survivorship plan review due; confirm appropriateness before contacting patient.
PHM saved action
PHM action: UNCONTROLLED_HBA1C
status=new | imported | outreach=phone 2026-05-08 08:00 | next review=2026-06-09 | Review evidence for HbA1c above target; confirm appropriateness before contacting patient.
Latest Measurements
Select
There are no items to display.
0-0 of 0
Measure
Latest
Date
Previous
Trend
Hba1c
9 %
2026-02-08
9.4 %
-0.4
Systolic Bp
108 mmHg
2025-03-23
134 mmHg
-26.0
Diastolic Bp
77 mmHg
2025-03-23
87 mmHg
-10.0
Bmi
30.3 kg/m2
2025-03-06
No previous
Reference
Egfr
77 mL/min/1.73m2
2026-05-04
No previous
Reference
Albumin Creatinine Ratio
35.5 mg/mmol
2026-03-10
No previous
Reference
Ldl Cholesterol
2.3 mmol/L
2026-05-02
1.5 mmol/L
+0.8
Fasting Glucose
10.6 mmol/L
2026-05-19
8 mmol/L
+2.6
Smoking Status
never smoker
2026-05-23
No previous
Reference
Page 1 / 1
Timeline
cohort_run
Cohort: Smoking / Lung Screening review cohort
completed | Chart evidence: Care element: smoking_status never smoker form | probable
phm_workflow
PHM action: SURVIVORSHIP_PLAN_DUE
status=in_review | imported | outreach=portal 2026-03-12 11:10 | next review=2026-07-17 | Review evidence for Survivorship plan review due; confirm appropriateness before contacting patient.
phm_workflow
PHM action: UNCONTROLLED_HBA1C
status=new | imported | outreach=phone 2026-05-08 08:00 | next review=2026-06-09 | Review evidence for HbA1c above target; confirm appropriateness before contacting patient.
clinical_flag
Age-eligible screening missing
completed | medium | clinical_note | Patient appears age-eligible for preventive screening, but no recent screening completion evidence is present.
clinical_flag
Survivorship plan review due
new | medium | report | Cancer history is active/imported; survivorship plan or surveillance schedule should be confirmed.
clinical_flag
HbA1c above target
in_review | high | structured_fact | Latest HbA1c 9.0% suggests above-target glycemic control and needs clinician review.
alert
Diabetes control flag: HbA1c above target
Generated from longitudinal lab trend.
note
SOAP note
T2DM review. Home glucose pattern limited due to missed checks. Discussed nutrition, exercise, foot care, and medication adherence. Plan: repeat HbA1c and review cardiovascular/renal risk.
note
consult
Survivorship care reviewed for history of prostate cancer survivor. Patient asks about surveillance schedule and late effects.
note
preventive care
Preventive care review: age-eligible cancer screening discussed. No completed screening result found in imported records.
report
Consult
Oncology follow-up for prostate cancer survivor. No active recurrence noted in this synthetic report. Ongoing surveillance, late effects, and primary care coordination discussed.
note
SOAP note
Follow-up visit. Medication list reviewed, allergies checked, and preventive care status discussed. Patient reports no acute concern. Plan: update labs/vitals and arrange follow-up as clinically indicated.
report
Laboratory
HbA1c, fasting glucose, lipid panel, creatinine/eGFR, and urine ACR reviewed for diabetes follow-up.
report
Consult
Eye care report: diabetic eye screening risk reviewed. Follow-up interval documented; no urgent ocular change in this synthetic report.
SOAP note
T2DM review. Home glucose pattern limited due to missed checks. Discussed nutrition, exercise, foot care, and medication adherence. Plan: repeat HbA1c and review cardiovascular/renal risk.
consult
Survivorship care reviewed for history of prostate cancer survivor. Patient asks about surveillance schedule and late effects.
preventive care
Preventive care review: age-eligible cancer screening discussed. No completed screening result found in imported records.
SOAP note
Follow-up visit. Medication list reviewed, allergies checked, and preventive care status discussed. Patient reports no acute concern. Plan: update labs/vitals and arrange follow-up as clinically indicated.
Consult
Oncology follow-up for prostate cancer survivor. No active recurrence noted in this synthetic report. Ongoing surveillance, late effects, and primary care coordination discussed.
Laboratory
HbA1c, fasting glucose, lipid panel, creatinine/eGFR, and urine ACR reviewed for diabetes follow-up.
Consult
Eye care report: diabetic eye screening risk reviewed. Follow-up interval documented; no urgent ocular change in this synthetic report.
Patient Context
ProviderJuliana Davies
LanguageFrench
Phone416-555-1280
Emailcatherine.glenn60@example.test
Sourcestructured_json
Review tasks
Age-eligible screening missing
Patient appears age-eligible for preventive screening, but no recent screening completion evidence is present.
completed | Chart evidence: Care element: smoking_status never smoker form | probable
phm_workflow
PHM action: SURVIVORSHIP_PLAN_DUE
status=in_review | imported | outreach=portal 2026-03-12 11:10 | next review=2026-07-17 | Review evidence for Survivorship plan review due; confirm appropriateness before contacting patient.
phm_workflow
PHM action: UNCONTROLLED_HBA1C
status=new | imported | outreach=phone 2026-05-08 08:00 | next review=2026-06-09 | Review evidence for HbA1c above target; confirm appropriateness before contacting patient.
clinical_flag
Age-eligible screening missing
completed | medium | clinical_note | Patient appears age-eligible for preventive screening, but no recent screening completion evidence is present.
clinical_flag
Survivorship plan review due
new | medium | report | Cancer history is active/imported; survivorship plan or surveillance schedule should be confirmed.
clinical_flag
HbA1c above target
in_review | high | structured_fact | Latest HbA1c 9.0% suggests above-target glycemic control and needs clinician review.
alert
Diabetes control flag: HbA1c above target
Generated from longitudinal lab trend.
care_element
smoking_status
never smoker
care_element
fasting_glucose
care_element
egfr
care_element
ldl_cholesterol
care_element
albumin_creatinine_ratio
care_element
hba1c
note
SOAP note
T2DM review. Home glucose pattern limited due to missed checks. Discussed nutrition, exercise, foot care, and medication adherence. Plan: repeat HbA1c and review cardiovascular/renal risk.
care_element
immunization
Influenza vaccine documented
note
consult
Survivorship care reviewed for history of prostate cancer survivor. Patient asks about surveillance schedule and late effects.
note
preventive care
Preventive care review: age-eligible cancer screening discussed. No completed screening result found in imported records.
report
Consult
Oncology follow-up for prostate cancer survivor. No active recurrence noted in this synthetic report. Ongoing surveillance, late effects, and primary care coordination discussed.
note
SOAP note
Follow-up visit. Medication list reviewed, allergies checked, and preventive care status discussed. Patient reports no acute concern. Plan: update labs/vitals and arrange follow-up as clinically indicated.
care_element
systolic_bp
care_element
diastolic_bp
care_element
diastolic_bp
care_element
systolic_bp
care_element
hba1c
care_element
bmi
report
Laboratory
HbA1c, fasting glucose, lipid panel, creatinine/eGFR, and urine ACR reviewed for diabetes follow-up.
care_element
systolic_bp
care_element
diastolic_bp
report
Consult
Eye care report: diabetic eye screening risk reviewed. Follow-up interval documented; no urgent ocular change in this synthetic report.